Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors
Conditions: Neuroendocrine Tumors
ClinicalTrials.gov Identifier: NCT00137774

Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract
Conditions: Gastrointestinal Cancer; Carcinoma, Neuroendocrine
ClinicalTrials.gov Identifier: NCT00353015

Octreotide and Interferon alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Condition: Advanced Neuroendocrine Carcinoma
ClinicalTrials.gov Identifier: NCT00569127

Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors
Condition: Metastatic Neuroendocrine Tumors
ClinicalTrials.gov Identifier: NCT00590343

The Safety and Efficacy of CPTK 787/ZK222584 in Patients With Metastatic Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
ClinicalTrials.gov Identifier: NCT00627198